Insulet Corporation (NASDAQ:PODD) managed to eke out gains of 0.4% in intraday trade. The share price increased by 0.12 points to $30.1. Till last observation, the net money flow was recorded at a negative $(-3.92) million. The total inflow of $0.09 million in upticks was completely overshadowed by an outflow of $4.01 million in downticks, giving the up/down ratio a value of 0.02. The shares have seen a change of -3.56% in the past week.A block trade occurred in the company shares in which the composite value of the upticks was $0 million and the composite value in downticks was $3.94 million. The resultant up/down ratio for the block exchange was 0. The block trade had a negative money flow of $(-3.94) million.
Insulet Corporation has dropped 7.4% in the last five trading days, however, the shares have posted positive gains of 7.04% in the last 4 weeks. Insulet Corporation has dropped 8.57% during the last 3-month period . Year-to-Date the stock performance stands at -23.57%.
Currently the company Insiders own 1.9% of Insulet Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 16.79% . During last six month period, the net percent change held by insiders has seen a change of 13.72%. . On the companys insider trading activities, The Securities and Exchange Commission has divulged that Sommer Regina O, director of Insulet Corp, had unloaded 8,019 shares at an average price of $30.42 in a transaction dated on May 25, 2016. The total value of the transaction was worth $243,938.
Insulet Corporation (NASDAQ:PODD) witnessed a decline in the market cap on Friday as its shares dropped 3.6% or 1.08 points. After the session commenced at $29.89, the stock reached the higher end at $30.29 while it hit a low of $28.87. With the volume soaring to 516,306 shares, the last trade was called at $28.9. The company has a 52-week high of $40.21. The company has a market cap of $1,652 million and there are 57,159,581 shares in outstanding. The 52-week low of the share price is $23.94.
Insulet Corporation is a medical device company engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin infusion system for people with insulin-dependent diabetes. The Companys principal offices are located in Billerica, Massachusetts. Features of the OmniPod System include two-part design, no tubing, and automated cannula insertion. The OmniPod System consists of two devices that communicate wirelessly: the OmniPod, a small, lightweight, disposable insulin infusion device worn beneath clothing; and the PDM, a handheld device much like a personal digital assistant that wirelessly programs the OmniPod with insulin delivery instructions. The OmniPod will operate up to 72 hours (but no more than 80 hours) after it is first activated. The OmniPod System does not have external tubing and features an automated, hands-free cannula insertion system.